Elevance Health Inc. Stock News

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Elevance Health (ELV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Shares of Elevance Health (ELV) rose to their highest level since late 2022 on Thursday as the health insurance provider posted better-than-expected results and raised its guidance amid lower costs.

Elevance Health Inc.'s stock rose 4.7% on Thursday, after the health insurer posted better-than-expected profit for the first quarter and raised a full-year guidance metric, offsetting a revenue short

Elevance Health (ELV) has a leftover capacity of around $3.6 billion under its share buyback authorization.

While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics co

Elevance Health (ELV) came out with quarterly earnings of $10.64 per share, beating the Zacks Consensus Estimate of $10.54 per share. This compares to earnings of $9.46 per share a year ago.

Elevance (ELV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

We have narrowed our search to five large-cap stocks that are poised to beat on earnings results this week. These are: NFLX, ISRG, ELV, EFX, CSX.

Elevance Health (ELV) forms an alliance with CD&R to enhance primary care delivery by making collective use of the partners' assets and subsequently, reduce overall costs of care.

The first-quarter results of Elevance (ELV) are likely to reflect higher product revenues and Commercial Individual membership growth.